Hoshi Corporation Starts Accepting Orders for Manufacturing Made-in-Japan Cosmetic Products by Fully Utilizing Bonded Cosmetic Factory

Food and Healthcare Press Releases Tuesday January 29, 2019 12:00
TOKYO--29 Jan--Kyodo JBN - AsiaNet/ InfoQuest
Hoshi Corporation, the Tokyo-based OEM and ODM cosmetic company, has received a license from the Okinawa Regional Customs to operate Japan's first bonded cosmetic factory.

The company is strongly geared toward exporting OEM and ODM cosmetic products with its logistics base in Okinawa, as driven by growing international demand for made-in-Japan cosmetic products, mainly to Asian and Oceania countries. Currently Hoshi has been dealing with over 700 overseas clients.

The bonded cosmetic factory operation license has enabled the company to fully use its high manufacturing technology and quality to reduce costs and realize swift production, thereby offering you affordable manufacturing plans thanks to reduced tariff and storage costs.

Website: http://hoshicorp.jp/bondedfactory/
Devices available for access: PCs, mobile phones
  • Features of the Okinawa factory:

The Okinawa factory is located in the Global Logistics Center (Okinawa GLC) that is operated by Okinawa Yamato Transport Co., Ltd., a subsidiary of Yamato Holdings Co., Ltd., a major player in the logistic industry in Japan.

By operating the bonded factory in the Okinawa GLC area neighboring Naha International Airport, Hoshi can undertake filling, packaging, assembling operations and store materials in the bonded area.
  • Business advantages by fully utilizing Okinawa bonded factory:
TARIFF CUTS
You are NOT required to bear import duties imposed on cosmetic packages.
EXPRESS DELIVERY
The Okinawa factory is adjacent to Naha International Airport, allowing the lead time of import and export to be reduced.
GLOBAL LOGISTICS NETWORK
Make use of the global network of the Yamato transportation group, the largest logistic company in Japan.
RELIABLE MADE-IN-JAPAN BULK
High quality is assured by manufacturing under the Japanese GMP.
SMALL-LOT PRODUCTION
Accept manufacturing orders starting with a lot of 500 units
REDUCE STORAGE COST
Product storage inside the Okinawa GLC is available at low cost.
SUPPORT CROSS-BORDER EC BUSINESS
Hoshino supports cross-border e-commerce business by utilizing its logistic facility as your business hub.
  • Business flow by utilizing Okinawa bonded factory:
STEP 1
Transfer cosmetic bulk to Okinawa factory from Hoshi's domestic cosmetic manufacturing factories.
STEP 2
Import Korean or Taiwanese cosmetic packaging.
*Selected high-quality Taiwanese and Korean packaging can be imported at preferential tariff rates.
STEP 3
Fill cosmetic bulk into imported containers.
Final finishing process of assembling and packaging
STEP 4
Export to your clients/agents (a third country) without custom clearance.
Image: Comparison chart
https://kyodonewsprwire.jp/prwfile/release/M104323/201901212418/_prw_PI1fl_1S4u95E7.jpg
Geographical advantage of Okinawa, the southernmost island of Japan:
  • The only 24-hour operating customs clearance system in Japan
  • Less than 4 hours on flight to major Asian cities
  • Located at the center of the mass Asian market of 2 billion customers
Advantages of choosing Hoshi Corporation as your OEM partner:
  • Track record of exports to more than 20 countries
  • Decades of cosmetic OEM business experience with over 700 domestic and overseas clients, with over 20,000 product types handled
  • 4 manufacturing factories in Japan (Tokyo, Gunma, Saitama and Okinawa)
  • A proven and trusted service that has been steadily forged since Hoshi's founding
Company Profile
Name: Hoshi Corporation
Address: 31-2, Kanda Higashi Matsushita-Cho, Chiyoda-Ku, Tokyo, 101-0042, JAPAN
CEO: Tsuneo Hoshino
Founded: April 30, 1975
Capital: 80,000,000 yen
Business lines:
  • Sales of cosmetics, pharmaceuticals and health foods
  • Planning and sales of containers and packaging materials
  • Planning and contract manufacturing of cosmetics, pharmaceuticals and health foods
SOURCE: Hoshi Corporation
AsiaNet 77240

Latest Press Release

Mallinckrodt Announces Interim Analysis Results for Therakos(R) Platform Phase 3 Clinical Trial in Treatment of Pediatric Patients with Steroid Refractory Acute Graft-versus-Host Disease

-- Overall response rate exceeded specified study midpoint target (n=25); company elects to discontinue further patient enrollment as allowed by protocol -- Mallinckrodt plc (NYSE:MNK), a leading global specialty pharmaceutical company, today announced...

Takeda, Microsoft and EURORDIS release report with action plan to help rare disease community shorten the diagnostic odyssey

- Global Commission's recommendations focus on three solution pathways that leverage technology to address key elements of the rare disease diagnostic odyssey - Rare diseases remain undiagnosed as patients struggle to navigate complex health systems to...

Pivotal Phase III Data for BAVENCIO(R) (avelumab) Plus INLYTA(R) (axitinib) in Advanced Renal Cell Carcinoma Published in the New England Journal of Medicine

- JAVELIN Renal 101 shows significant improvement in progression-free survival with a hazard ratio of 0.69 in patients regardless of PD-L1 expression - US FDA has granted Priority Review to BAVENCIO plus INLYTA for patients with advanced renal cell...

ISABS เตรียมจัดการประชุมว่าด้วยการแพทย์ส่วนบุคคลที่โครเอเชีย พร้อมเชิญเจ้าของรางวัลโนเบลร่วมบรรยาย

International Society for Applied Biological Sciences (ISABS) ร่วมกับ Mayo Clinic และ St. Catherine Hospital เตรียมจัดการประชุม "ISABS Conference on Forensic and Anthropologic Genetics and Mayo Clinic Lectures in Individualized Medicine" ครั้งที่ 11...

ISABS: Personalized Medicine Conference With Nobel Laureates to Be Held in Split, Croatia

International Society for Applied Biological Sciences (ISABS), Mayo Clinic and St. Catherine Hospital are organizing "11th ISABS Conference on Forensic and Anthropologic Genetics and Mayo Clinic Lectures in Individualized Medicine"(http://www.isabs.net)...

Related Topics